Holocene Advisors’s Athenahealth, Inc. ATHN Stock Holding History

Holocene Advisors’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-8,783	Closed	-$1.17M	–	929
2018 Q3	$1.17M	Buy	8,783 +7,205	+457%	+$1.08M	0.02%	234
2018 Q2	$251K	Buy	+1,578	New	+$234K	0.01%	519
2018 Q1	–	Sell	-6,748	Closed	-$898K	–	800
2017 Q4	$898K	Buy	+6,748	New	+$862K	0.02%	208

Other funds holding ATHN

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Holocene Advisors's ATHN Position: Q4 2018 in Review

Holocene Advisors sold out of Athenahealth, Inc. (ATHN) in Q4 2018, closing a stake of 8,783 shares — an estimated $1.17M sold.

Holocene Advisors first reported a position in ATHN in Q4 2017 and held it in 3 quarters. The position peaked at $1.17M in Q3 2018. 263 funds tracked by Wall St. Rank hold ATHN as of Q4 2018.

Holocene Advisors reported no remaining Athenahealth, Inc. position as of Q4 2018 after selling out during the quarter.
Holocene Advisors sold 8,783 Athenahealth, Inc. shares in Q4 2018, an estimated $1.17M.
Holocene Advisors first reported a position in Athenahealth, Inc. in Q4 2017 and held it in 3 quarters.
Holocene Advisors's Athenahealth, Inc. position peaked at $1.17M in Q3 2018.
263 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q4 2018.

Based on Holocene Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.